Clinical Trial Update: A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiotherapy combined with raltitrexed and irinotecan in recurrent or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Radiotherapy
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Fudan University | Conditions: Recurrent Colorectal Cancer | Phase 2 | Status: UNKNOWN